These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18251376)

  • 1. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(3):174-81. PubMed ID: 18251376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening life insurance applicants with hemoglobin A1c.
    Rogers GP
    J Insur Med; 2008; 40(1):83. PubMed ID: 18924372
    [No Abstract]   [Full Text] [Related]  

  • 4. Using liver enzymes as screening tests to predict mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality associated with bilirubin levels in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening life insurance applicants for hemoglobin A1c: concerns about standardization and genetic variants.
    Warber KD; Roberts BD
    J Insur Med; 2009; 41(1):86. PubMed ID: 19518011
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening life insurance applicants with hemoglobin A1c: a pilot study of cost-benefit.
    Hale CS
    J Insur Med; 2007; 39(2):89-97. PubMed ID: 17941333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2014 CRL Build Study of Life Insurance Applicants.
    Fulks M; Dolan VF; Stout RL
    J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
    J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
    [No Abstract]   [Full Text] [Related]  

  • 13. Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
    Mancini GBJ; Maron DJ; Hartigan PM; Spertus JA; Kostuk WJ; Berman DS; Teo KK; Weintraub WS; Boden WE;
    J Am Coll Cardiol; 2019 Apr; 73(16):2049-2058. PubMed ID: 31023428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interaction of Acute and Chronic Glycemia on the Relationship of Hyperglycemia, Hypoglycemia, and Glucose Variability to Mortality in the Critically Ill.
    Krinsley JS; Rule P; Pappy L; Ahmed A; Huley-Rodrigues C; Prevedello D; Preiser JC
    Crit Care Med; 2020 Dec; 48(12):1744-1751. PubMed ID: 33031146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Liver Function Tests with Mortality in an Insurance Applicant Population.
    Rigatti SJ; Stout R
    J Insur Med; 2022 Jul; 49(3):172-182. PubMed ID: 36378891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Risk of Low BMI in Life Insurance Applicants.
    Rigatti SJ; Stout R
    J Insur Med; 2024 Jul; 51(1):8-16. PubMed ID: 38802091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total hemoglobin count has significant impact on A1C - Data from National Health and Nutrition Examination Survey 1999-2014.
    Wang D; Wang Y; Madhu S; Liang H; Bray CL
    Prim Care Diabetes; 2019 Aug; 13(4):316-323. PubMed ID: 30718167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.